Target intelligence / Profile preview

ABCF2-H2BK1 readthrough (ABCF2-H2BK1)

Target
ABCF2-H2BK1
Molecular classification
Other
01

Overview

ABCF2-H2BK1 readthrough is a gene locus resulting from readthrough transcription between the ABCF2 gene (encoding a member of the ATP-binding cassette (ABC) transporter family) and a downstream histone H2B-like gene (H2BK1)[2][3][5]. This entity encodes a chimeric transcript, but has not been widely characterized as an independent protein with established function, targetability, or clinical significance. It is catalogued as a protein-coding locus, but both function and biological importance remain unclear; its existence primarily reflects an annotation artifact due to readthrough events between neighboring genes[2][3][5]. Key points supporting this annotation: - The genomic entry corresponds to a readthrough transcript, not a unique, well-characterized protein or classical drug target[2][3]. - There is no functional or mechanistic data supporting its role as a receptor, enzyme, transporter, or established molecular target for drug discovery[2][3][5][6]. - No known interacting drugs, disease roles, biomarkers, or mechanism-of-action data are associated with the locus in literature or protein databases as of this update[2][3][5][6][7]. Reason for is_incorrect: true - This "target" reflects a readthrough artifact and does not represent an established, actionable therapeutic or molecular target as defined in pharmacology, translational medicine, or molecular biology[2][3][5]. No validated function can be assigned, and its alternative names also refer to the same locus. In molecular target databases, such entries are generally not used for therapeutic targeting. Summary: ABCF2-H2BK1 readthrough is a genomic artifact resulting from readthrough transcription between ABCF2 and H2BK1, with no recognized functional significance or therapeutic targeting potential[2][3][5].

Other names
ABCF2-H2BE1ABCF2-H2B proteinABCF2-H2B readthroughABCF2-H2BE1 readthroughABCF2-H2BK1
02

Mechanism of action

Null

Beyond the preview

Go deeper on ABCF2-H2BK1 readthrough (ABCF2-H2BK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABCF2-H2BK1 readthrough (ABCF2-H2BK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call